Mei Li
Scientist at the Pediatrics Research Institute of Children's Hospital of Soochow University studying brain injury, who contributed to a study of how PIP4K2A protects the brain after stroke
Pediatrics Research Institute · Soochow Key Laboratory of Prevention and Treatment of Child Brain Injury · Children's Hospital of Soochow University · Suzhou, Jiangsu, China
Mei Li is based at the Pediatrics Research Institute, Children's Hospital of Soochow University, in a group focused on mechanisms of hypoxic-ischemic and developmental brain injury. She is a co-author on the Suzhou team's work identifying PIP4K2A as a protective factor in cerebral ischemia/reperfusion injury.
PubMed also credits Li as the corresponding author of a 2026 study of Trim47 protecting the neonatal blood-brain barrier, a 2025 study of FAM20C in hypoxic-ischemic brain damage from the same institute, and a 2026 paper with a dual Soochow/Massachusetts General Hospital affiliation — pointing to an active, pediatrics-focused neuroscience researcher with an international collaboration.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | PIP4K2A Attenuates Cerebral Ischemia/Reperfusion Injury by Reducing the TRIB3-p62 Complex Burden and Modulating AKT/mTOR Signaling. MA2026 Co-author from the Children's Hospital of Soochow University Pediatrics Research Institute on the PIP4K2A/TRIB3-p62/AKT-mTOR stroke-protection study. |
Co-authors in the Atlas 4
People with a profile here who share at least one study with Mei Li.
ShowHide
- Bodun Ma Neurology researcher in Suzhou and first author of a 2026 study on how the enzyme PIP4K2A protects the brain after stroke by restoring autophagy through AKT/mTOR
- Hongxuan Feng Neurologist at Suzhou Municipal Hospital and senior author of a 2026 stroke study proposing PIP4K2A as a protector of brain tissue through AKT/mTOR signalling and autophagy
- Shuai Yu Neurology researcher who contributed to a study showing that the lipid kinase PIP4K2A protects the brain after ischaemic stroke by relieving a block on autophagy and boosting AKT/mTOR signalling
- Xiaotian Yu Stroke neurology researcher who contributed to a study of how PIP4K2A limits brain injury after ischaemia and reperfusion through the TRIB3–p62 and AKT–mTOR pathways
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.